It takes two to tango: Combinations of conventional cytotoxics with compounds targeting the vascular endothelial growth factorâvascular endothelial growth factor receptor pathway in patients with solid malignancies-Reference-Cited by-同舟云学术

It takes two to tango: Combinations of conventional cytotoxics with compounds targeting the vascular endothelial growth factorâvascular endothelial growth factor receptor pathway in patients with solid malignancies

Published:2010-01 Issue:1 Volume:101 Page:7-15
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Boere Ingrid A.,Hamberg Paul,Sleijfer Stefan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2009.01369.x/fullpdf

Reference77 articles.

1. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors;Hirota;Science (New York, NY),1998

2. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial;Verweij;Lancet,2004

3. Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group;Heinrich;J Clin Oncol,2008

4. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis;Shibuya;Exp Cell Res,2006

5. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma;Rini;J Clin Oncol,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical In Vitro Investigation of MDM2 Inhibition in Combination with Antiangiogenic Therapy for Breast Cancer Treatment;Scientia Pharmaceutica;2023-02-20

2. A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT);Therapeutic Advances in Medical Oncology;2022-01

3. Therapeutic Targeting of the Tumor Microenvironment;Cancer Discovery;2021-04

4. Resistance Mechanisms to Anti-angiogenic Therapies in Cancer;Frontiers in Oncology;2020-02-27

5. Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects;Clinical Therapeutics;2019-08